Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth Emerges as a Core Driver of the Preclinical Imaging Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Preclinical Imaging Market Through 2025?
In the past few years, the preclinical imaging market has witnessed a significant increase in its size. The market is projected to surge from $3.46 billion in 2024 to $3.69 billion in 2025, recording a compound annual growth rate (CAGR) of 6.7%. This growth during the historic period can be traced back to government initiatives, the rising incidences of diseases, wider application range, heightened awareness, and the growth of emerging markets.

What's the Projected Size of the Global Preclinical Imaging Market by 2029?
Expectations are set for the preclinical imaging market to experience a significant increase in size in the coming years. The prediction is a rise to $4.83 billion by 2029, with a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this predicted growth during the forecast period include the adoption of personalized medicine, developments in molecular imaging, the outsourcing of drug development, regulatory support, and a surge in chronic diseases. The forecast period will also see an increasing trend of green imaging technologies, technological innovations, escalated R&D activities, and collaborations and partnerships, along with real-time imaging.

View the full report here:
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Top Growth Drivers in the Preclinical Imaging Industry: What's Accelerating the Market?
The surge in chronic illnesses is predicted to drive the expansion of the preclinical imaging market. Chronic illnesses are prevalent, long-lasting health issues that typically persist for more than three months. Managing such ailments requires continuous medical attention and they can greatly affect an individual's lifestyle. To detect chronic diseases, preclinical imaging equipment is employed to examine bone and lung conditions, and also to observe disease progression, contributing to a broader understanding of the disease. For example, in September 2022, the World Health Organization's '2022 Highlights' reported 41 million worldwide deaths due to Noncommunicable diseases (NCDs) or chronic diseases, representing 74% of all deaths. This includes 17.9 million deaths resulting from heart conditions, 9.3 million from cancer, 4.1 million from chronic breathing problems, and 2.0 million from diabetes. It is the rising trend of chronic disease incidence, therefore, that is fuelling preclinical imaging market growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

What Trends Will Shape the Preclinical Imaging Market Through 2029 and Beyond?
The advent of product innovations is emerging as a significant trend in the preclinical imaging sector. In order to maintain their stance in the market, leading corporations in this field are creating cutting-edge products. For example, in May 2022, Fujifilm VisualSonics Inc., a biomedical firm based in Canada specializing in the creation of imaging systems, unveiled the Vevo F2 for preclinical imaging.
This pioneering product is the debut preclinical ultrasonic and photoacoustic imaging system that operates at ultra-low to ultra-high frequencies (71 MHz-1 MHz). The Vevo F2 boasts HD image processing technology and a completely novel signal pathway which enhances both image clarity and frame rates. Further, the system can be adapted to meet certain accuracy needs of imaging. Moreover, it incorporates features such as high-definition image processing technology, a newly introduced signal pathway, adjustable system architecture, broad selections of anatomical targets, and last but not least, high-resolution imaging. This makes it suitable for a wide array of research applications.

What Are the Main Segments in the Preclinical Imaging Market?
The preclinical imaging market covered in this report is segmented -

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:
1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging
2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)
3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems
4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems
5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems
6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems
7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Which Top Companies are Driving Growth in the Preclinical Imaging Market?
Major companies operating in the preclinical imaging market include Thermo Fisher Scientific Inc., FUJIFILM Visualsonics Inc., Konica Minolta Inc., Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc., Promega Corporation, Ion Beam Applications S.A, Nihon Kohden, Piramal Enterprises Ltd, LI-COR Biosciences Inc., Aspect Imaging Ltd, Capintec Inc., Spectral Instruments Inc., Mediso Ltd, MR Solutions Ltd, Biospace Lab S. A., Scintica Instrumentation Inc., Trifoil Imaging, Bioscan Inc., CytoSMART Technologies B.V, Inviscan SAS, Kubtec X-ray, MILabs B.V., SCANCO Medical AG, Cristal Therapeutics.

Which Regions Will Dominate the Preclinical Imaging Market Through 2029?
North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12393

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.